Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Pharma
Verona's new COPD drug Ohtuvayre racked up sales of $42M in 2024
Verona is off to a strong start with its launch of COPD drug Ohtuvayre as it generated sales of $42 million in 2024, the company reported Tuesday.
Kevin Dunleavy
Jan 7, 2025 1:27pm
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
Nov 8, 2024 3:31pm
AstraZeneca backs campaign to improve lives of COPD patients
Nov 4, 2024 10:40am
AstraZeneca's new TV spot for COPD drug Breztri sets sail
Oct 22, 2024 7:35am
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
Sep 27, 2024 9:40am
GSK posts COPD win for Nucala as rival nears possible approval
Sep 6, 2024 9:40am
